DWM
AGN

Destination Wealth Management’s Allergan plc AGN Stock Holding History

Destination Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$15K – 797
2019
Q1 		$15K Buy
+100
New +$14.5K ﹤0.01% 418
2018
Q2 		– Sell
-73
Closed -$12K – 684
2018
Q1 		$12K Buy
+73
New +$12.2K ﹤0.01% 382
2017
Q2 		– Sell
-1,375
Closed -$329K – 166
2017
Q1 		$329K Buy
+1,375
New +$320K 0.02% 126

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Destination Wealth Management's AGN Position: Q2 2019 in Review

Destination Wealth Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 100 shares — an estimated $15K sold.

Destination Wealth Management first reported a position in AGN in Q1 2017 and held it in 3 quarters. The position peaked at $329K in Q1 2017. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Destination Wealth Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Destination Wealth Management sold 100 Allergan plc shares in Q2 2019, an estimated $15K.
  • Destination Wealth Management first reported a position in Allergan plc in Q1 2017 and held it in 3 quarters.
  • Destination Wealth Management's Allergan plc position peaked at $329K in Q1 2017.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Destination Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.